For the quarter ending 2026-03-31, SIBN had -$8,705K decrease in cash & cash equivalents over the period. -$3,439K in free cash flow.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net loss | -4,334 | -1,644 | -4,566 | -12,694 |
| Stock-based compensation | 6,025 | 5,977 | 6,226 | 13,321 |
| Depreciation and amortization | 1,617 | 1,638 | 1,486 | 2,646 |
| Accounts receivable credit losses | 90 | 33 | 62 | 475 |
| Amortization of discount and premium on marketable securities | 564 | 611 | 700 | 1,740 |
| Inventory reserve | 388 | 213 | 549 | 1,235 |
| Amortization of debt issuance costs | 29 | 29 | 29 | 59 |
| Loss on disposal of property and equipment | -332 | -185 | -814 | -628 |
| Accounts receivable | 1,142 | 3,391 | 2,234 | -2,598 |
| Inventory | 2,038 | -1,650 | 2,042 | 8,292 |
| Prepaid expenses and other assets | -777 | 1,449 | -512 | 93 |
| Accounts payable | 2,098 | -3,008 | 662 | 583 |
| Accrued liabilities and other | -5,640 | 2,106 | 1,537 | -3,464 |
| Net cash used in operating activities | -2,362 | 1,728 | 2,335 | -4,738 |
| Maturities of marketable securities | 46,130 | 49,000 | 52,000 | 104,100 |
| Purchases of marketable securities | 51,285 | 34,686 | 59,070 | 98,770 |
| Purchases of property and equipment | 1,077 | 1,288 | 2,955 | 4,171 |
| Net cash (used in) provided by investing activities | -6,232 | 13,026 | -10,025 | 1,159 |
| Proceeds from follow-on public offering, net of underwriting discounts, commissions and offering costs | - | 0 | - | - |
| Proceeds from debt financing, net of debt issuance cost | - | 0 | - | - |
| Repayments of debt financing | - | 0 | - | - |
| Proceeds from issuance of common stock under employee stock purchase plan | - | 639 | 0 | 1,568 |
| Final payment fee related to debt | - | 0 | - | - |
| Proceeds from the exercise of stock options | 34 | 390 | 11 | 768 |
| Net cash provided by financing activities | 34 | 1,029 | 11 | 2,336 |
| Effect of exchange rate changes on cash and cash equivalents | -145 | -30 | 16 | 445 |
| Net increase (decrease) in cash and cash equivalents | -8,705 | 15,753 | -7,663 | -798 |
| Beginning of period | 42,240 | 8,461 | 34,948 | - |
| End of period | 33,535 | 15,753 | 26,487 | - |
SI-BONE, Inc. (SIBN)
SI-BONE, Inc. (SIBN)